Search clinical trials for: Warfarin 3mg

Total 12602 results

Sarah Sabry Hashem

Completed

Warfarin Initiation in Mechanical Mitral Valve Replacement Patients

Mitral Valve Disease

Egypt
GlaxoSmithKline

Completed

A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

Asthma

Germany, South Africa, Bulgaria
Boehringer Ingelheim

Terminated

Dabigatran Etexilate in Patients With Mechanical Heart Valves (RE-ALIGN)

Heart Valve Diseases

Belgium, Canada, Czech Republic, Denmark, France, Germany, Netherlands, Norway, Poland, Sweden
Boehringer Ingelheim

Terminated

Follow on Study From RE-ALIGN

Thromboembolism | Heart Valve Prosthesis

Belgium, Canada, Czech Republic, Denmark, France, Germany, Netherlands, Norway, Poland
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

The Study of Warfarin Maintenance Dose in Chinese Patients (WADCH)

Atrial Fibrillation | Heart Valve Disease | Pulmonary Artery Embolism

China
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Unknown

Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves

Pregnancy | Heart; Complications, Valve, Prosthesis

Turkey
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

Healthy

United States
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Unknown

Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis

Thrombosis

Turkey
J2H Biotech

Completed

Phase 1 Study to Investigate Safety, Tolerability, PK/PK of J2H-1702 in Healthy Males

Non-alcoholic Steatohepatitis

Korea, Republic of
University Hospital, Brest

Completed

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP) (PADIS TVP)

Recurrent Venous Thromboembolism | Idiopathic Deep Vein Thrombosis

France
University Hospital, Brest

Completed

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study. (PADIS EP)

Pulmonary Embolism

France
University of Padova

Completed

Ultrasound Findings to Adjust the Duration of Anticoagulation (AESOPUS)

Deep Vein Thrombosis

Italy
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil (WARFA)

Atrial Fibrillation

Brazil
Duke University
National Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research Institute

Terminated

AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)

Idiopathic Pulmonary Fibrosis

United States
Azienda Ospedaliera Universitaria Policlinico

Completed

Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants (Exten-DACUS)

Deep Vein Thrombosis

Italy
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Completed

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

Healthy Volunteer

China
National University Hospital, Singapore

Unknown

Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

Indications for Warfarin Therapy

Singapore, Malaysia
University of Karachi
Advanced Education & Research Center; Karachi Institute of Heart Diseases

Recruiting

Left Atrial Appendage (LAA) Clot With Severe Mitral Stenosis

Left Atrial Appendage Aneurysm | Mitral Stenosis

Pakistan
Jonsson Comprehensive Cancer Center
Novartis Pharmaceuticals

Completed

Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)

Heart Diseases | Cardiovascular Diseases | Cerebrovascular Disorders | Atrial Fibrillation | Arrhythmia | Cerebrovascular Accident | Thrombophlebitis | Cerebral Embolism and Thrombosis
National Taiwan University Hospital

Unknown

The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR

Deep Venous Thromboembolism

Taiwan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Prevention of Recurrent Venous Thromboembolism (PREVENT)

Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Peripheral Vascular Diseases | Thromboembolism | Venous Thromboembolism
Korea University Anam Hospital

Unknown

Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation

Atrial Fibrillation

Korea, Republic of
University of Florida

Withdrawn

PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care

Blood Coagulation Disorders

United States
Astellas Pharma Inc

Completed

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Atrial Fibrillation

Taiwan, Japan, Korea, Republic of, New Zealand, Singapore, South Africa, Thailand, Australia, Hong Kong, Malaysia
Aalborg University Hospital

Completed

Prospective Trial of a Validated Algorithm for Warfarin Dosing

Anticoagulation
Iverson Genetic Diagnostics, Inc.

Suspended

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) (WARFARIN)

Atrial Fibrillation | Pulmonary Embolism | DVT | Prosthetic Replacement of Mitral Valve | Anti-coagulation Therapy | Joint Surgery Multiple

United States
Chinese PLA General Hospital

Unknown

Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism | Heart Valve Disease

China
China National Center for Cardiovascular Diseases

Completed

Genotype-guided Versus Standard for Warfarin Dosing

Atrial Fibrillation | Valvular Heart Disease

China
Gwen McMillin

Completed

Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)

Bleeding | Venous Thromboembolism

United States
McMaster University
Epitome Pharmaceuticals

Terminated

Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin

Hypoprothrombinemia

Canada
Cancer Research Campaign Clinical Trials Centre

Completed

Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters

Thromboembolism

United Kingdom
Eli Lilly and Company

Completed

A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

Lymphoma, Malignant | Solid Tumor

France
University of California, San Francisco

Completed

Assessment of 2012 Bioequivalence Standards for Warfarin

Healthy

United States
Ankara University

Unknown

VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management

Atrial Fibrillation | Peripheral Vascular Disease | Deep Vein Thrombosis | Pulmonary Embolism | Cardiac Thrombus | Heart Valve Replacement (Mechanical or Biological With AF) | Cardiomyopathy (Ischemic or Dilated)

Turkey
Hamilton Health Sciences Corporation
Heart and Stroke Foundation of Canada

Completed

International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures

Heart Defect | Triscupid Atresia

Canada, Australia
AstraZeneca

Completed

Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects

Rheumatoid Arthritis | Healthy Subjects

United Kingdom
Hamilton Health Sciences Corporation

Completed

Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients (FORESPEAK-0)

Myocardial Infarction | Ischemic Stroke | Atrial Fibrillation | Venous Thromboembolism

Canada
Academia Sinica, Taiwan
China Medical University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical...

Completed

Pharmacogenetic Dosing of Warfarin

Stroke | Venous Thrombosis | Atrial Fibrillation | Atrial Flutter

Taiwan
The Third Xiangya Hospital of Central South University

Completed

Genotype-guided Warfarin Individualized Treatment

Atrial Fibrillation | Deep Venous Thrombosis

China
Xi Zhang
Sun Yat-sen University

Unknown

A Trial of Genotype-based Warfarin Initiation in Patients With Mechanical Prosthetic Heart Valve (SYSU-WARFA)

Heart Valve Diseases | Anticoagulation Treatment Overdose

China
Baylor Research Institute

Completed

Impact of Telehealth Warfarin Education on Patient Retention

Medication Adherence | Educational Problems
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

Essential Hypertension
Wuhan Asia Heart Hospital

Completed

D-Dimer Determined Anticoagulation INTENSITY in Patients With Mechanical Valve Replacement (3D-INTENSITY)

Heart Valve Disease

China
Chang Gung Memorial Hospital

Completed

The Educational Effectiveness for Atrial Fibrillation Patients Under Warfarin Treatment

Atrial Fibrillation
Robert Pendleton
University of Louisville

Completed

Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy (PerMIT)

Blood Clotting

United States
Wuhan Asia Heart Hospital

Unknown

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy (REDUCE)

Valve Heart Disease | Anticoagulants; Increased

China
Marshall University

Unknown

Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) (HIT)

Heparin-induced Thrombocytopenia

United States
Tasly Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin

Healthy

United States
Texas Cardiac Arrhythmia Research Foundation
Stanford University; Case Western Reserve University; University of Kansas; California... and other collaborators

Completed

Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE)

Thromboembolism

United States

Search clinical trials for: Warfarin 3mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations